BIVIW — BIOVIE INC.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1580149 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 0 — -5,649,932 -5,605,070 11,037,959 7,732,817 4,509,301
Jun 2026 0 — -5,719,456 -5,645,532 14,250,462 8,977,370 3,980,192
Mar 2026 0 — -5,385,377 -5,270,299 17,514,621 13,098,976 1,907,029
Dec 2025 0 — -6,262,305 -6,069,475 22,503,293 20,540,585 3,238,259

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-19,024,806
Investing CF
$0
Financing CF
$10,457,629
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-374,260,653
Inventory
—
Receivables
$2,151,440
ST Investments
—
EBIT TTM
$-22,054,962
Pretax Income TTM
$-22,072,863
Interest Exp TTM
$17,901
Analysts
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Jun 2026 0 -22,651,733 -22,072,863 14,250,462 3,980,192 10,270,270 -19,024,806
Jun 2025 0 -18,066,200 -17,542,120 21,562,199 2,550,214 19,011,985 -19,025,205
Jun 2024 0 -32,179,585 -32,120,533 25,208,345 9,702,130 15,506,215 -27,945,024
Jun 2023 0 -45,080,448 -50,255,815 35,104,730 19,764,444 15,340,286 -40,252,881

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-22,072,863
OpCashFlow TTM
—
Assets (Latest)
$17,514,621
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.26T $1415.55 —
JNJ JOHNSON & JOHNSON $670.92B $278.70 —
ABBV AbbVie Inc. $517.59B $292.82 —
MRK Merck & Co., Inc. $353.44B $143.37 —
NVS NOVARTIS AG $302.46B $159.13 —

News headlines (Yahoo Finance, 1h cache)

BioVie says bezisterim shows distinct responses in two Long COVID patient groups
2026-11-16 14:57 · Yahoo
BioVie Presents New Biomarker Data Highlighting Biomarker-Defined Endotypes and Neuropeptide Y Response to Bezisterim at the 4th Long COVID International Conference 2026
2026-11-16 13:00 · Yahoo
BioVie to present additional Parkinson’s drug data at international conference
2026-11-10 14:32 · Yahoo
BioVie Invited to Present Data on Bezisterim in Parkinson’s Disease at the AD/PD2027 International Conference on Alzheimer's & Parkinson’s Diseases
2026-11-10 13:00 · Yahoo
BioVie identifies two Long COVID patient groups with distinct responses to bezisterim
2026-11-09 14:28 · Yahoo
BioVie Presents New Biomarker Data from the ADDRESS-LC Trial of Bezisterim in Long COVID at the NIH RECOVER-TLC Third Annual Workshop
2026-11-09 13:00 · Yahoo
Fusion Power, Global Capital, Branded Streaming and Neurology Breakthroughs: New to The Street Show #779 Premieres Tonight on Bloomberg Television
2026-11-07 17:05 · Yahoo
BioVie to raise $4.74 million in registered direct offering
2026-11-04 14:01 · Yahoo
BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules
2026-11-04 13:00 · Yahoo
BioVie to present new Long COVID biomarker data at Nice conference
2026-11-02 14:50 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.